Professor Heather A Payne


Consultant Clinical Oncologist, University College London Hospitals

“I cannot tell you how much I enjoy working with everyone at the Centre. It is great to feel part of your team”

Renowned for:

Decision-making for localized disease
External beam radiotherapy
High dose rate (HDR) brachytherapy
Hormone therapy
Second opinion

For patients who have:

Localised prostate cancer
Locally advanced prostate cancer
Metastatic prostate cancer

Career highlights:

Heather specialises in the management of urological malignancies and is actively involved in clinical research. As well as her research into hormones and radiotherapy she has pioneered a programme of high-dose rate (HDR) brachytherapy which is a minimally invasive treatment for prostate cancer. Currently chairman of the British Uro-oncology Group (BUG), Heather serves on the Prostate Cancer Charter for Action and the Department of Health Prostate Cancer Advisory Group; she is a Trustee of Prostate UK and of the Prostate Cancer Research Centre. She enjoys and has particular expertise in helping patients with quality of life and decision-making issues with regard to their treatment options.